Free Trial

Life360 (LIF) Competitors

Life360 logo
$42.23 +0.63 (+1.51%)
(As of 11/20/2024 ET)

LIF vs. ALLE, WPP, CART, ULS, MEDP, STN, GLOB, HQY, BILI, and LYFT

Should you be buying Life360 stock or one of its competitors? The main competitors of Life360 include Allegion (ALLE), WPP (WPP), Maplebear (CART), UL Solutions (ULS), Medpace (MEDP), Stantec (STN), Globant (GLOB), HealthEquity (HQY), Bilibili (BILI), and Lyft (LYFT). These companies are all part of the "business services" industry.

Life360 vs.

Allegion (NYSE:ALLE) and Life360 (NASDAQ:LIF) are both industrial products companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, media sentiment, dividends, analyst recommendations, community ranking and valuation.

Allegion received 420 more outperform votes than Life360 when rated by MarketBeat users. However, 81.25% of users gave Life360 an outperform vote while only 58.43% of users gave Allegion an outperform vote.

CompanyUnderperformOutperform
AllegionOutperform Votes
433
58.43%
Underperform Votes
308
41.57%
Life360Outperform Votes
13
81.25%
Underperform Votes
3
18.75%

Allegion has a net margin of 15.36% compared to Life360's net margin of -4.72%. Allegion's return on equity of 45.64% beat Life360's return on equity.

Company Net Margins Return on Equity Return on Assets
Allegion15.36% 45.64% 14.09%
Life360 -4.72%-4.03%-3.16%

Allegion presently has a consensus price target of $144.60, indicating a potential upside of 3.71%. Life360 has a consensus price target of $44.75, indicating a potential upside of 5.97%. Given Life360's stronger consensus rating and higher possible upside, analysts plainly believe Life360 is more favorable than Allegion.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Allegion
1 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.80
Life360
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
3.00

92.2% of Allegion shares are held by institutional investors. 0.3% of Allegion shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Life360 had 13 more articles in the media than Allegion. MarketBeat recorded 26 mentions for Life360 and 13 mentions for Allegion. Allegion's average media sentiment score of 0.81 beat Life360's score of 0.62 indicating that Allegion is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Allegion
7 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Life360
8 Very Positive mention(s)
9 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Allegion has higher revenue and earnings than Life360.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Allegion$3.65B3.32$540.40M$6.5121.42
Life360$304.52M10.36-$28.17MN/AN/A

Summary

Allegion beats Life360 on 9 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LIF vs. The Competition

MetricLife360Data processing & preparation IndustryIndustrial SectorNASDAQ Exchange
Market Cap$3.15B$4.34B$9.58B$8.82B
Dividend YieldN/A3.08%2.02%4.07%
P/E RatioN/A34.4722.2917.81
Price / Sales10.365.277.4874.56
Price / CashN/A30.1616.9432.53
Price / BookN/A6.174.274.68
Net Income-$28.17M$42.17M$413.78M$226.08M
7 Day Performance-3.76%-1.55%2.69%-1.04%
1 Month Performance-5.06%3.18%8.16%1.04%
1 Year PerformanceN/A7.83%29.97%26.28%

Life360 Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LIF
Life360
1.0368 of 5 stars
$42.23
+1.5%
$44.75
+6.0%
N/A$3.11B$304.52M0.00600
ALLE
Allegion
4.0825 of 5 stars
$139.43
+0.9%
$144.60
+3.7%
+31.9%$12.01B$3.65B21.4212,400Analyst Revision
WPP
WPP
0.5145 of 5 stars
$51.41
-0.3%
N/A+15.7%$11.71B$18.46B0.00114,732Analyst Downgrade
News Coverage
CART
Maplebear
4.4472 of 5 stars
$41.58
-2.8%
$47.29
+13.7%
+60.9%$10.99B$3.04B27.913,380Analyst Revision
ULS
UL Solutions
2.3154 of 5 stars
$52.82
+2.1%
$49.00
-7.2%
N/A$10.35B$2.68B0.0015,233
MEDP
Medpace
4.7711 of 5 stars
$326.09
+3.5%
$380.00
+16.5%
+18.2%$9.79B$1.89B28.555,900
STN
Stantec
3.2074 of 5 stars
$84.13
+1.3%
N/A+19.3%$9.47B$4.80B38.2428,000
GLOB
Globant
4.0595 of 5 stars
$215.70
+3.4%
$229.06
+6.2%
+3.0%$9.29B$2.35B56.3229,150Analyst Forecast
Gap Up
HQY
HealthEquity
3.6708 of 5 stars
$102.96
+0.3%
$107.23
+4.1%
+54.3%$8.97B$999.59M85.803,150News Coverage
BILI
Bilibili
2.2522 of 5 stars
$19.19
+3.6%
$19.69
+2.6%
+31.7%$7.67B$3.19B-20.868,801Earnings Report
Analyst Forecast
Gap Up
LYFT
Lyft
3.9777 of 5 stars
$16.77
+1.2%
$17.48
+4.3%
+61.4%$6.87B$4.40B0.002,945

Related Companies and Tools


This page (NASDAQ:LIF) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners